CAR-T cell therapy: a potential new strategy against prostate cancer

Prostate cancer (PCa) is one of the main causes of cancer-related death in men. In the present immunotherapy era, several immunotherapeutic agents have been evaluated in PCa with poor results, possibly due to its low mutational burden. The recent development of chimeric antigen receptor (CAR)-T cell...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:J Immunother Cancer
Prif Awduron: Schepisi, Giuseppe, Cursano, Maria Concetta, Casadei, Chiara, Menna, Cecilia, Altavilla, Amelia, Lolli, Cristian, Cerchione, Claudio, Paganelli, Giovanni, Santini, Daniele, Tonini, Giuseppe, Martinelli, Giovanni, De Giorgi, Ugo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: BioMed Central 2019
Pynciau:
Review
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6794851/
https://ncbi.nlm.nih.gov/pubmed/31619289
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0741-7
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg